Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank43
5Y CAGR-21.2%
Year-over-Year Change
Free cash flow yield
5Y CAGR
-21.2%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.76% | -52.2% |
| 2024 | 7.88% | -2.1% |
| 2023 | 8.04% | +669.4% |
| 2022 | -1.41% | -303.3% |
| 2021 | 0.69% | -94.4% |
| 2020 | 12.43% | +75.7% |
| 2019 | 7.07% | +1571.5% |
| 2018 | 0.42% | -59.0% |
| 2017 | 1.03% | -78.8% |
| 2016 | 4.86% | - |